Literature DB >> 17311915

Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2.

Stefaan Sansen1, Jason K Yano, Rosamund L Reynald, Guillaume A Schoch, Keith J Griffin, C David Stout, Eric F Johnson.   

Abstract

Microsomal cytochrome P450 family 1 enzymes play prominent roles in xenobiotic detoxication and procarcinogen activation. P450 1A2 is the principal cytochrome P450 family 1 enzyme expressed in human liver and participates extensively in drug oxidations. This enzyme is also of great importance in the bioactivation of mutagens, including the N-hydroxylation of arylamines. P450-catalyzed reactions involve a wide range of substrates, and this versatility is reflected in a structural diversity evident in the active sites of available P450 structures. Here, we present the structure of human P450 1A2 in complex with the inhibitor alpha-naphthoflavone, determined to a resolution of 1.95 A. alpha-Naphthoflavone is bound in the active site above the distal surface of the heme prosthetic group. The structure reveals a compact, closed active site cavity that is highly adapted for the positioning and oxidation of relatively large, planar substrates. This unique topology is clearly distinct from known active site architectures of P450 family 2 and 3 enzymes and demonstrates how P450 family 1 enzymes have evolved to catalyze efficiently polycyclic aromatic hydrocarbon oxidation. This report provides the first structure of a microsomal P450 from family 1 and offers a template to study further structure-function relationships of alternative substrates and other cytochrome P450 family 1 members.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311915     DOI: 10.1074/jbc.M611692200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  123 in total

Review 1.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

2.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

3.  Highly predictive and interpretable models for PAMPA permeability.

Authors:  Hongmao Sun; Kimloan Nguyen; Edward Kerns; Zhengyin Yan; Kyeong Ri Yu; Pranav Shah; Ajit Jadhav; Xin Xu
Journal:  Bioorg Med Chem       Date:  2016-12-31       Impact factor: 3.641

4.  QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.

Authors:  J Sridhar; M Foroozesh; C L Klein Stevens
Journal:  SAR QSAR Environ Res       Date:  2011-10-17       Impact factor: 3.000

5.  Significant increase in phenacetin oxidation on L382V substitution in human cytochrome P450 1A2.

Authors:  Qingbiao Huang; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2010-03-24       Impact factor: 3.922

Review 6.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

7.  Exploring CYP1A1 as anticancer target: homology modeling and in silico inhibitor design.

Authors:  Abhay T Sangamwar; Leena B Labhsetwar; Sharad V Kuberkar
Journal:  J Mol Model       Date:  2008-07-30       Impact factor: 1.810

8.  Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug-like Molecules.

Authors:  Hongmao Sun; Henrike Veith; Menghang Xia; Christopher P Austin; Raymond R Tice; Ruili Huang
Journal:  Mol Inform       Date:  2012-10-11       Impact factor: 3.353

9.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

10.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.